- Home
- SPRY vs INVA Comparison
SPRY vs INVA Comparison
Compare SPRY & INVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SPRY | INVA |
|---|---|---|
| Founded | 2015 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.6B |
| IPO Year | N/A | 2004 |
Fundamental Metrics
Financial Performance| Metric | SPRY | INVA |
|---|---|---|
| Price | $10.95 | $19.64 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 5 |
| Target Price | $31.25 | ★ $36.80 |
| AVG Volume (30 Days) | ★ 1.6M | 940.8K |
| Earning Date | 11-10-2025 | 02-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 53.96 |
| EPS | N/A | ★ 1.52 |
| Revenue | $142,772,000.00 | ★ $388,521,000.00 |
| Revenue This Year | N/A | $13.23 |
| Revenue Next Year | $127.81 | $8.58 |
| P/E Ratio | ★ N/A | $12.81 |
| Revenue Growth | ★ 5459.66 | 10.14 |
| 52 Week Low | $6.66 | $16.52 |
| 52 Week High | $18.90 | $22.76 |
Technical Indicators
Market Signals| Indicator | SPRY | INVA |
|---|---|---|
| Relative Strength Index (RSI) | 55.38 | 44.35 |
| Support Level | $10.85 | $19.26 |
| Resistance Level | $11.43 | $20.23 |
| Average True Range (ATR) | 0.60 | 0.46 |
| MACD | -0.07 | -0.04 |
| Stochastic Oscillator | 57.47 | 45.54 |
Price Performance
Historical ComparisonAbout SPRY ARS Pharmaceuticals Inc.
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.
About INVA Innoviva Inc.
Innoviva Inc is a company with a portfolio of royalties healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.